Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Abercrombie George B
Relationship:  
City:   Durham
State:   NC
   
Insider Summary:
  
   
Companies Owned :   4    
Direct Shares   347,320    

Indirect Shares

   131,194      
Direct Value   $4,488,694    

Indirect Value

   $88,687      
Total Shares   478,514      
Total Value   $4,577,381      


Alaunos Therapeutics $4,215 Biocryst Pharmaceuticals Inc $123,182 Innoviva Inc $4,356,410 Fresh Tracks Therapeutics Ord Shs $4,887 Alaunos Therapeutics $4,215 Biocryst Pharmaceuticals Inc $123,182 Innoviva Inc $4,356,410 Fresh Tracks Therapeutics Ord Shs $4,887
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    2    

     Stock price went up :
    0   
    1    
     Stock price went down :
    0   
    1    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
 -13.3%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Alaunos Therapeutics TCRT Director 2010-04-05 25,000 2010-04-05 0    Premium*  
            Biocryst Pharmaceuticals Inc BCRX Director 2023-06-13 29,611 2013-03-05 0    Premium*  
            Innoviva Inc INVA Sr. VP & Chief Comm. O... 2018-08-21 285,479 2014-06-19 0    Premium*  
            Fresh Tracks Therapeutics Ord Shs FRTX 2019-08-31 7,230 2019-08-31 131,194    Premium*  
* Premium Members only  

Records found :    43         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 2
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2013-03-05 4 B $1.23 $3,690 D/D 3,000 3,000 2.73 -
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2013-11-12 4 B $6.19 $18,570 D/D 3,000 6,000 2.81 -
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2014-03-31 4 OE $1.71 $6,840 D/D 4,000 10,000 0 -
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2021-05-10 4 S $12.70 $88,900 D/D (7,000) 3,000 0 %
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2021-05-24 4 AS $13.90 $92,671 D/D (6,667) 3,000 0 %
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2021-05-24 4 OE $2.63 $17,534 D/D 6,667 9,667 0 -
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2021-07-15 4 OE $2.63 $13,150 D/D 5,000 8,000 0 -
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2021-07-15 4 AS $15.69 $78,450 D/D (5,000) 3,000 0 %
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2021-09-10 4 S $15.09 $1,116,660 D/D (74,000) 0 0 %
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2021-09-10 4 OE $1.71 $202,710 D/D 71,000 74,000 0 -
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2021-09-15 4 AS $15.06 $75,300 D/D (5,000) 0 0 %
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2021-09-15 4 OE $2.63 $13,150 D/D 5,000 5,000 0 -
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2021-11-15 4 AS $12.27 $61,350 D/D (5,000) 0 0 %
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2021-11-15 4 OE $3.32 $16,600 D/D 5,000 5,000 0 -
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2022-02-15 4 AS $18.50 $92,500 D/D (5,000) 0 0 %
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2022-02-15 4 OE $3.32 $16,600 D/D 5,000 5,000 0 -
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2022-04-18 4 OE $3.32 $16,600 D/D 5,000 5,000 0 -
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2022-04-18 4 AS $11.04 $55,200 D/D (5,000) 0 0 %
BCRX Biocryst Pharmaceuticals ... Director   •       •      –    2023-06-13 4 A $0.00 $0 D/D 16,745 29,611 0 -
FRTX Fresh Tracks Therapeutics...   –       •      –    2019-08-31 3 IO $0.00 $0 D/D 0 7,230 -
FRTX Fresh Tracks Therapeutics...   –       •      –    2019-08-31 3/A IO $0.00 $0 I/I 0 131,194 -
FRTX Fresh Tracks Therapeutics...   –       •      –    2019-08-31 3 IO $0.00 $0 I/I 0 24,164 -
INVA Innoviva Inc Sr. VP, Corp. Partnerships   •       –      –    2014-06-19 4 A $0.00 $0 D/D 10,000 10,000 0 -
INVA Innoviva Inc Sr. VP, Corp. Partnerships   •       –      –    2015-01-07 4 A $0.00 $0 D/D 71,429 81,429 0 -
INVA Innoviva Inc Sr. VP & Chief Comm. Officer   •       –      –    2016-01-14 4 A $0.00 $0 D/D 92,587 175,554 0 -
  43  Records found
  1  2      
  Page 1 of 2  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us